TABLE 1.

Baseline characteristics of the study populations

Characteristics	Intervention, n = 44	Control, n = 42	P Value
Demographics
Gender, female, n (%)	20 (45)	24 (57)	.29
Race, n (%)			.27
White	31 (70)	33 (78)
Black	2 (5)	4 (10)
Other	11 (25)	5 (12)
Ethnicity, n (%)			1.00
Hispanic/Latino	5 (11)	4 (10)
Others	39 (89)	38 (90)
Age, years			.18
Mean ± SD	11.9 ± 0.9	11.6 ± 0.8
Range	10–14	10–13
Insurance, n (%)			.95
Private	33 (75)	31 (74)
Public, Medicaid	10 (23)	9 (21)
Military, Tricare	1 (2)	1 (2)
None	0 (0)	1 (2)
Health self-care at baseline for the last 3 months
Daily strip test			.60
Mean ± SD	5.8 ± 2.2	5.7 ± 2.6
Range	2.1–11.4	2.4–15
Pump use, yes, n (%)	39 (89)	31 (74)	.07
Continuous glucose monitoring use, yes, n (%)	4 (9)	11 (26)	.048
Clinical characteristics at baseline
Hemoglobin A1c			.80
Mean ± SD	8.8 ± 1.2	8.8 ± 1.1
Range	6.6–11.6	6.2–11.4
Body mass index			.15
Mean ± SD	19.1 ± 2.2	20.2 ± 3.1
Range	15.4–26.4	15.7–28.3
Systolic blood pressure			.85
Mean ± SD	104.2–6.8	104.3 ± 9.5
Range	91–120	77–120
Diastolic blood pressure			.69
Mean ± SD	66.0 ± 5.3	66.3 ± 7.1
Range	55–77	46–81
No. of patients having severe hypoglycemia in the last 6 months
n (%)	0	0 (0)	1.00
No. of patients having severe hyperglycemia in the last 6 months
n (%)	2 (5)	3 (7)	.42
Type 1 diabetes duration, year			.53
Mean ± SD	4.5 ± 2.9	4.8 ± 2.7
Range	0.9–10.5	1.0–11.0
Smoke, yes, n (%)	0 (0)	0 (0)	1.00
Albuminuria, yes, n (%)	0 (0)	0 (0)	1.00